An integrated transcriptome and expressed variant analysis of sepsis survival and death

Genome Medicine

Volumn 6, Issue 11, 2014, Pages

  Tsalik, Ephraim L ^a,b   Langley, Raymond J ^c,d   Dinwiddie, Darrell L ^c,e   Miller, Neil A ^c,f   Yoo, Byunggil ^f   van Velkinburgh, Jennifer C ^c   Smith, Laurie D ^f   Thiffault, Isabella ^f   Jaehne, Anja K ^g   Valente, Ashlee M ^b   Henao, Ricardo ^h   Yuan, Xin ^h   Glickman, Seth W ⁱ   Rice, Brandon J ^c   McClain, Micah T ^a,b   Carin, Lawrence ^h   Corey, G R ^a,b   Ginsburg, Geoffrey S ^b   Cairns, Charles B ⁱ   Otero, Ronny M ^g,j   Fowler, Vance G ^b   Rivers, Emanuel P ^g   Woods, Christopher W ^a,b   Kingsmore, Stephen F ^c,e   more..

^a DURHAM VA MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c NATIONAL CENTER FOR GENOME RESOURCES   (United States)

^d LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^f CHILDREN S MERCY HOSPITAL   (United States)

^g HENRY FORD HOSPITAL   (United States)

^h Duke University   (United States)

ⁱ UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

RNA; TRANSCRIPTOME;

ADULT; ARTICLE; ENDOSOME; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GOLGI COMPLEX; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; METABOLOMICS; MITOCHONDRIAL GENE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEOMICS; RNA ANALYSIS; RNA SEQUENCE; SEPSIS; SURVIVAL; SURVIVOR; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84928005646     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/s13073-014-0111-5     Document Type: Article

References (71)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303-1310. 10.1097/00003246-200107000-00002, 11445675.
2. Adhikari NK, Fowler RA, Bhagwanjee S, Rubenfeld GD. Critical care and the global burden of critical illness in adults. Lancet 2010, 376:1339-1346. 10.1016/S0140-6736(10)60446-1, 20934212.
3. Kumar G, Kumar N, Taneja A, Kaleekal T, Tarima S, McGinley E, Jimenez E, Mohan A, Khan RA, Whittle J, Jacobs E, Nanchal R. Nationwide trends of severe sepsis in the 21st century (2000-2007). Chest 2011, 140:1223-1231. 10.1378/chest.11-0352, 21852297.
4. Liu V, Escobar GJ, Greene JD, Soule J, Whippy A, Angus DC, Iwashyna TJ. Hospital deaths in patients with sepsis from 2 independent cohorts. JAMA 2014, 312:90-92. 10.1001/jama.2014.5804, 24838355.
5. Winters BD, Eberlein M, Leung J, Needham DM, Pronovost PJ, Sevransky JE. Long-term mortality and quality of life in sepsis: a systematic review. Crit Care Med 2010, 38:1276-1283. 20308885.
6. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655.
7. Goswami ND, Pfeiffer CD, Horton JR, Chiswell K, Tasneem A, Tsalik EL. The state of infectious diseases clinical trials: a systematic review of ClinicalTrials.gov. PLoS One 2013, 8:e77086. 10.1371/journal.pone.0077086, 24146958.
8. Singer M. Biomarkers in sepsis. Curr Opin Pulm Med 2013, 19:305-309. 10.1097/MCP.0b013e32835f1b49, 23411577.
9. Ahn SH, Tsalik EL, Cyr DD, Zhang Y, van Velkinburgh JC, Langley RJ, Glickman SW, Cairns CB, Zaas AK, Rivers EP, Otero RM, Veldman T, Kingsmore SF, Lucas J, Woods CW, Ginsburg GS, Fowler VG. Gene expression-based classifiers identify Staphylococcus aureus infection in mice and humans. PLoS One 2013, 8:e48979. 10.1371/journal.pone.0048979, 23326304.
10. Glickman SW, Cairns CB, Otero RM, Woods CW, Tsalik EL, Langley RJ, van Velkinburgh JC, Park LP, Glickman LT, Fowler VG, Kingsmore SF, Rivers EP. Disease progression in hemodynamically stable patients presenting to the emergency department with sepsis. Acad Emerg Med 2010, 17:383-390. 10.1111/j.1553-2712.2010.00664.x, 20370777.
11. Langley RJ, Tsalik EL, Velkinburgh JC, Glickman SW, Rice BJ, Wang C, Chen B, Carin L, Suarez A, Mohney RP, Freeman DH, Wang M, You J, Wulff J, Thompson JW, Moseley MA, Reisinger S, Edmonds BT, Grinnell B, Nelson DR, Dinwiddie DL, Miller NA, Saunders CJ, Soden SS, Rogers AJ, Gazourian L, Fredenburgh LE, Massaro AF, Baron RM, Choi AM,et al.: An integrated clinico-metabolomic model improves prediction of death in sepsis. Sci Transl Med 2013, 5:195ra195..
12. Tsalik EL, Jaggers LB, Glickman SW, Langley RJ, van Velkinburgh JC, Park LP, Fowler VG, Cairns CB, Kingsmore SF, Woods CW. Discriminative value of inflammatory biomarkers for suspected sepsis. J Emerg Med 2012, 43:97-106. 10.1016/j.jemermed.2011.05.072, 22056545.
13. Tsalik EL, Jones D, Nicholson B, Waring L, Liesenfeld O, Park LP, Glickman SW, Caram LB, Langley RJ, van Velkinburgh JC, Cairns CB, Rivers EP, Otero RM, Kingsmore SF, Lalani T, Fowler VG, Woods CW. Multiplex PCR to diagnose bloodstream infections in patients admitted from the emergency department with sepsis. J Clin Microbiol 2010, 48:26-33. 10.1128/JCM.01447-09, 19846634.
14. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13:818-829. 10.1097/00003246-198510000-00009, 3928249.
15. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22:707-710. 10.1007/BF01709751, 8844239.
16. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977, 33:159-174. 10.2307/2529310, 843571.
17. Mudge J, Miller NA, Khrebtukova I, Lindquist IE, May GD, Huntley JJ, Luo S, Zhang L, van Velkinburgh JC, Farmer AD, Lewis S, Beavis WD, Schilkey FD, Virk SM, Black CF, Myers MK, Mader LC, Langley RJ, Utsey JP, Kim RW, Roberts RC, Khalsa SK, Garcia M, Ambriz-Griffith V, Harlan R, Czika W, Martin S, Wolfinger RD, Perrone-Bizzozero NI, Schroth GP, et al. Genomic convergence analysis of schizophrenia: mRNA sequencing reveals altered synaptic vesicular transport in post-mortem cerebellum. PLoS ONE 2008, 3:e3625. 10.1371/journal.pone.0003625, 18985160.
18. Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 2013, 29:15-21. 10.1093/bioinformatics/bts635, 23104886.
19. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M, DePristo MA. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 2010, 20:1297-1303. 10.1101/gr.107524.110, 20644199.
20. DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, Philippakis AA, del Angel G, Rivas MA, Hanna M, McKenna A, Fennell TJ, Kernytsky AM, Sivachenko AY, Cibulskis K, Gabriel SB, Altshuler D, Daly MJ. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 2011, 43:491-498. 10.1038/ng.806, 21478889.
21. Ewing B, Hillier L, Wendl MC, Green P. Base-calling of automated sequencer traces using phred. Genome Res 1998, 8:175-185. 10.1101/gr.8.3.175, 9521921.
22. Ewing B, Green P. Base-calling of automated sequencer traces using phred. Genome Res 1998, 8:186-194. 10.1101/gr.8.3.175, 9521922.
23. Saunders CJ, Miller NA, Soden SE, Dinwiddie DL, Noll A, Alnadi NA, Andraws N, Patterson ML, Krivohlavek LA, Fellis J, Humphray S, Saffrey P, Kingsbury Z, Weir JC, Betley J, Grocock RJ, Margulies EH, Farrow EG, Artman M, Safina NP, Petrikin JE, Hall KP, Kingsmore SF: Rapid whole-genome sequencing for genetic disease diagnosis in neonatal intensive care units. Sci Transl Med 2012, 4:154ra135..
24. McLaren W, Pritchard B, Rios D, Chen Y, Flicek P, Cunningham F. Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor. Bioinformatics 2010, 26:2069-2070. 10.1093/bioinformatics/btq330, 20562413.
25. Stenson PD, Ball EV, Howells K, Phillips AD, Mort M, Cooper DN. The Human Gene Mutation Database: providing a comprehensive central mutation database for molecular diagnostics and personalized genomics. Hum Genomics 2009, 4:69-72. 10.1186/1479-7364-4-2-69, 20038494.
26. Storey JD. A direct approach to false discovery rates. Roy Stat Soc: Series B (Statistical Methodology) 2002, 64:479-498. 10.1111/1467-9868.00346.
27. Storey JD, Taylor JE, Siegmund D: Strong control, conservative point estimation and simultaneous conservative consistency of false discovery rates: a unified approach. J Teh Roy Stat Soc: Series B (Statistical Methodology) 2004, 66:187-205..
28. Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Statist Soc Ser 1995, B 57:289-300..
29. Chen J, Bardes EE, Aronow BJ, Jegga AG. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res 2009, 37:W305-W311. 10.1093/nar/gkp427, 19465376.
30. Li B, Leal SM. Methods for detecting associations with rare variants for common diseases: application to analysis of sequence data. Am J Hum Genet 2008, 83:311-321. 10.1016/j.ajhg.2008.06.024, 18691683.
31. An integrated map of genetic variation from 1,092 human genomes. Nature 2012, 491:56-65. 10.1038/nature11632.
32. Exome Variant Server, NHLBI GO: Exome Sequencing Project (ESP), Seattle, WA. 2012. [http://evs.gs.washington.edu/EVS/].
33. Wang Z, Gerstein M, Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 2009, 10:57-63. 10.1038/nrg2484, 19015660.
34. Baranzini SE, Mudge J, van Velkinburgh JC, Khankhanian P, Khrebtukova I, Miller NA, Zhang L, Farmer AD, Bell CJ, Kim RW, May GD, Woodward JE, Caillier SJ, McElroy JP, Gomez R, Pando MJ, Clendenen LE, Ganusova EE, Schilkey FD, Ramaraj T, Khan OA, Huntley JJ, Luo S, Kwok PY, Wu TD, Schroth GP, Oksenberg JR, Hauser SL, Kingsmore SF. Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis. Nature 2010, 464:1351-1356. 10.1038/nature08990, 20428171.
35. Sugarbaker DJ, Richards WG, Gordon GJ, Dong L, De Rienzo A, Maulik G, Glickman JN, Chirieac LR, Hartman ML, Taillon BE, Du L, Bouffard P, Kingsmore SF, Miller NA, Farmer AD, Jensen RV, Gullans SR, Bueno R. Transcriptome sequencing of malignant pleural mesothelioma tumors. Proc Natl Acad Sci U S A 2008, 105:3521-3526. 10.1073/pnas.0712399105, 18303113.
36. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, Kingsmore SF, Schroth GP, Burge CB. Alternative isoform regulation in human tissue transcriptomes. Nature 2008, 456:470-476. 10.1038/nature07509, 18978772.
37. Bernard GR, Margolis BD, Shanies HM, Ely EW, Wheeler AP, Levy H, Wong K, Wright TJ. Extended evaluation of recombinant human activated protein C United States Trial (ENHANCE US): a single-arm, phase 3B, multicenter study of drotrecogin alfa (activated) in severe sepsis. Chest 2004, 125:2206-2216. 10.1378/chest.125.6.2206, 15189943.
38. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344:699-709. 10.1056/NEJM200103083441001, 11236773.
39. Martí-Carvajal AJ, Solà I, Lathyris D, Cardona AF. Human recombinant activated protein C for severe sepsis. Cochrane Database of Systematic Reviews 2011, 4. 21491390.
40. Carney DS, Davies BA, Horazdovsky BF. Vps9 domain-containing proteins: activators of Rab5 GTPases from yeast to neurons. Trends Cell Biol 2006, 16:27-35. 10.1016/j.tcb.2005.11.001, 16330212.
41. Carre JE, Orban JC, Re L, Felsmann K, Iffert W, Bauer M, Suliman HB, Piantadosi CA, Mayhew TM, Breen P, Stotz M, Singer M. Survival in critical illness is associated with early activation of mitochondrial biogenesis. Am J Respir Crit Care Med 2010, 182:745-751. 10.1164/rccm.201003-0326OC, 20538956.
42. Langley RJ, Tipper JL, Bruse S, Baron RM, Tsalik EL, Huntley J, Rogers AJ, Jaramillo RJ, O'Donnell D, Mega WM, Keaton M, Kensicki E, Gazourian L, Fredenburgh LE, Massaro AF, Otero RM, Fowler VG, Rivers EP, Woods CW, Kingsmore SF, Sopori ML, Perrella MA, Choi AMK, Harrod KS. Integrative " omic" analysis of experimental bacteremia identifies a metabolic signature that distinguishes human sepsis from systemic inflammatory response syndromes. Am J Respir Crit Care Med 2014, 190:445-455. 10.1164/rccm.201404-0624OC, 25054455.
43. Rogers AJ, McGeachie M, Baron RM, Gazourian L, Haspel JA, Nakahira K, Fredenburgh LE, Hunninghake GM, Raby BA, Matthay MA, Otero RM, Fowler VG, Rivers EP, Woods CW, Kingsmore S, Langley RJ, Choi AM. Metabolomic derangements are associated with mortality in critically ill adult patients. PLoS One 2014, 9:e87538. 10.1371/journal.pone.0087538, 24498130.
44. Baudouin SV, Saunders D, Tiangyou W, Elson JL, Poynter J, Pyle A, Keers S, Turnbull DM, Howell N, Chinnery PF. Mitochondrial DNA and survival after sepsis: a prospective study. Lancet 2005, 366:2118-2121. 10.1016/S0140-6736(05)67890-7, 16360789.
45. Gomez R, O'Keeffe T, Chang LY, Huebinger RM, Minei JP, Barber RC. Association of mitochondrial allele 4216C with increased risk for complicated sepsis and death after traumatic injury. J Trauma 2009, 66:850-857. discussion 857-858, 10.1097/TA.0b013e3181991ac8, 19276764.
46. Kloss-Brandstatter A, Pacher D, Schonherr S, Weissensteiner H, Binna R, Specht G, Kronenberg F. HaploGrep: a fast and reliable algorithm for automatic classification of mitochondrial DNA haplogroups. Hum Mutat 2011, 32:25-32. 10.1002/humu.21382, 20960467.
47. Wallace DC, Chalkia D. Mitochondrial DNA genetics and the heteroplasmy conundrum in evolution and disease. Cold Spring Harb Perspect Biol 2013, 5:a021220. 10.1101/cshperspect.a021220, 24186072.
48. Ramos A, Santos C, Mateiu L, Gonzalez Mdel M, Alvarez L, Azevedo L, Amorim A, Aluja MP. Frequency and pattern of heteroplasmy in the complete human mitochondrial genome. PLoS One 2013, 8:e74636. 10.1371/journal.pone.0074636, 24098342.
49. Li M, Schonberg A, Schaefer M, Schroeder R, Nasidze I, Stoneking M. Detecting heteroplasmy from high-throughput sequencing of complete human mitochondrial DNA genomes. Am J Hum Genet 2010, 87:237-249. 10.1016/j.ajhg.2010.07.014, 20696290.
50. Severino P, Silva E, Baggio-Zappia GL, Brunialti MK, Nucci LA, Rigato O, da Silva ID, Machado FR, Salomao R. Patterns of gene expression in peripheral blood mononuclear cells and outcomes from patients with sepsis secondary to community acquired pneumonia. PLoS One 2014, 9:e91886. 10.1371/journal.pone.0091886, 24667684.
51. Wong HR, Cvijanovich N, Allen GL, Lin R, Anas N, Meyer K, Freishtat RJ, Monaco M, Odoms K, Sakthivel B, Shanley TP. Genomic expression profiling across the pediatric systemic inflammatory response syndrome, sepsis, and septic shock spectrum. Crit Care Med 2009, 37:1558-1566. 10.1097/CCM.0b013e31819fcc08, 19325468.
52. Tang BM, McLean AS, Dawes IW, Huang SJ, Lin RC. Gene-expression profiling of peripheral blood mononuclear cells in sepsis. Crit Care Med 2009, 37:882-888. 10.1097/CCM.0b013e31819b52fd, 19237892.
53. Lambeck S, Weber M, Gonnert FA, Mrowka R, Bauer M. Comparison of sepsis-induced transcriptomic changes in a murine model to clinical blood samples identifies common response patterns. Front Microbiol 2012, 3:284. 10.3389/fmicb.2012.00284, 23024636.
54. Kamisoglu K, Sleight KE, Calvano SE, Coyle SM, Corbett SA, Androulakis IP. Temporal metabolic profiling of plasma during endotoxemia in humans. Shock 2013, 40:519-526. 10.1097/SHK.0000000000000063, 24089011.
55. Mickiewicz B, Duggan GE, Winston BW, Doig C, Kubes P, Vogel HJ, Alberta Sepsis N. Metabolic profiling of serum samples by 1H nuclear magnetic resonance spectroscopy as a potential diagnostic approach for septic shock. Crit Care Med 2014, 42:1140-1149. 10.1097/CCM.0000000000000142, 24368342.
56. Cao Z, Yende S, Kellum JA, Angus DC, Robinson RA. Proteomics reveals age-related differences in the host immune response to sepsis. J Proteome Res 2014, 13:422-432. 10.1021/pr400814s, 24266763.
57. Kalenka A, Feldmann RE, Otero K, Maurer MH, Waschke KF, Fiedler F. Changes in the serum proteome of patients with sepsis and septic shock. Anesth Analg 2006, 103:1522-1526. 10.1213/01.ane.0000242533.59457.70, 17122233.
58. Shen Z, Want EJ, Chen W, Keating W, Nussbaumer W, Moore R, Gentle TM, Siuzdak G. Sepsis plasma protein profiling with immunodepletion, three-dimensional liquid chromatography tandem mass spectrometry, and spectrum counting. J Proteome Res 2006, 5:3154-3160. 10.1021/pr060327k, 17081067.
59. Wang H, Zhang P, Chen W, Feng D, Jia Y, Xie L. Serum microRNA signatures identified by Solexa sequencing predict sepsis patients' mortality: a prospective observational study. PLoS One 2012, 7:e38885. 10.1371/journal.pone.0038885, 22719975.
60. Ma Y, Vilanova D, Atalar K, Delfour O, Edgeworth J, Ostermann M, Hernandez-Fuentes M, Razafimahatratra S, Michot B, Persing DH, Ziegler I, Toros B, Molling P, Olcen P, Beale R, Lord GM. Genome-wide sequencing of cellular microRNAs identifies a combinatorial expression signature diagnostic of sepsis. PLoS One 2013, 8:e75918. 10.1371/journal.pone.0075918, 24146790.
61. Wang HJ, Zhang PJ, Chen WJ, Jie D, Dan F, Jia YH, Xie LX. Characterization and Identification of novel serum microRNAs in sepsis patients with different outcomes. Shock 2013, 39:480-487. 10.1097/SHK.0b013e3182940cb8, 23612084.
62. Otto GP, Sossdorf M, Claus RA, Rodel J, Menge K, Reinhart K, Bauer M, Riedemann NC. The late phase of sepsis is characterized by an increased microbiological burden and death rate. Crit Care 2011, 15:R183. 10.1186/cc10332, 21798063.
63. Mizumura K, Cloonan SM, Haspel JA, Choi AM. The emerging importance of autophagy in pulmonary diseases. Chest 2012, 142:1289-1299. 10.1378/chest.12-0809, 23131937.
64. Simard JC, Cesaro A, Chapeton-Montes J, Tardif M, Antoine F, Girard D, Tessier PA. S100A8 and S100A9 induce cytokine expression and regulate the NLRP3 inflammasome via ROS-dependent activation of NF-kappaB(1.). PLoS One 2013, 8:e72138. 10.1371/journal.pone.0072138, 23977231.
65. Sugimoto J, Hatakeyama T, Isobe M. Isolation and mapping of a putative b subunit of human ATP synthase (ATP-BL) from human leukocytes. DNA Res 1999, 6:29-35. 10.1093/dnares/6.1.29, 10231027.
66. Bandyopadhyay S, Chiang CY, Srivastava J, Gersten M, White S, Bell R, Kurschner C, Martin C, Smoot M, Sahasrabudhe S, Barber DL, Chanda SK, Ideker T. A human MAP kinase interactome. Nat Methods 2010, 7:801-805. 10.1038/nmeth.1506, 20936779.
67. Buday L, Egan SE, Rodriguez Viciana P, Cantrell DA, Downward J. A complex of Grb2 adaptor protein, Sos exchange factor, and a 36-kDa membrane-bound tyrosine phosphoprotein is implicated in ras activation in T cells. J Biol Chem 1994, 269:9019-9023. 7510700.
68. Stork B, Engelke M, Frey J, Horejsi V, Hamm-Baarke A, Schraven B, Kurosaki T, Wienands J. Grb2 and the non-T cell activation linker NTAL constitute a Ca(2+)-regulating signal circuit in B lymphocytes. Immunity 2004, 21:681-691. 10.1016/j.immuni.2004.09.007, 15539154.
69. Hart CP, Martin JE, Reed MA, Keval AA, Pustelnik MJ, Northrop JP, Patel DV, Grove JR. Potent inhibitory ligands of the GRB2 SH2 domain from recombinant peptide libraries. Cell Signal 1999, 11:453-464. 10.1016/S0898-6568(99)00017-0, 10400318.
70. Romero F, Ramos-Morales F, Dominguez A, Rios RM, Schweighoffer F, Tocque B, Pintor-Toro JA, Fischer S, Tortolero M. Grb2 and its apoptotic isoform Grb3-3 associate with heterogeneous nuclear ribonucleoprotein C, and these interactions are modulated by poly(U) RNA. J Biol Chem 1998, 273:7776-7781. 10.1074/jbc.273.13.7776, 9516488.
71. Iwashyna TJ, Netzer G, Langa KM, Cigolle C. Spurious inferences about long-term outcomes: the case of severe sepsis and geriatric conditions. Am J Respir Crit Care Med 2012, 185:835-841. 10.1164/rccm.201109-1660OC, 22323301.